A safe nanoemulsion adjuvant produces a killed-virus nasal vaccine for smallpox.

被引：0
|
作者：
Bielinska, AU [1 ]
Janczak, KW [1 ]
Landers, JJ [1 ]
Baker, JR [1 ]
机构：
[1] Univ Michigan, Ctr Biol & Nanotechnol, Ann Arbor, MI 48109 USA
来源：
CLINICAL IMMUNOLOGY | 2005年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 22 条
  • [21] Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo
    Zhang, Linghua
    Tian, Xingshan
    Zhou, Fengzhen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (13) : 1732 - 1740
  • [22] Chemically Synthesized Alcaligenes Lipid A Shows a Potent and Safe Nasal Vaccine Adjuvant Activity for the Induction of Streptococcus pneumoniae-Specific IgA and Th17 Mediated Protective Immunity
    Yoshii, Ken
    Hosomi, Koji
    Shimoyama, Atsushi
    Wang, Yunru
    Yamaura, Haruki
    Nagatake, Takahiro
    Suzuki, Hidehiko
    Lan, Huangwenxian
    Kiyono, Hiroshi
    Fukase, Koichi
    Kunisawa, Jun
    MICROORGANISMS, 2020, 8 (08) : 1 - 20
123